N/A
N=641
Acute Coronary Syndrome KCMC
Acute Coronary Syndrome
Bottom Line
View on ClinicalTrials.gov: NCT04563546 ↗Enrolled (actual)
641
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcome: Primary: Acceptability as Measured by the Acceptability of Intervention Measure (AIM) — 4.82 score on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Quality Improvement (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Duke University
- Primary completion
- Sep 2024
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability as Measured by the Acceptability of Intervention Measure (AIM) |
4.82 | — |
| SECONDARY Number of Participants Presenting With Chest Pain or Shortness of Breath Who Undergo ECG and Cardiac Biomarker Testing During Their ED Stay |
431 | <0.001 sig |
| SECONDARY Survival of Participants With Acute Coronary Syndrome (ACS) at 30 Days After Enrollment |
90 | 0.739 |
| SECONDARY Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin at Baseline |
101 | <0.001 sig |
| SECONDARY Number of Participants With Acute Coronary Syndrome (ACS) Taking Aspirin 30 Days After Enrollment |
42 | — |
Summary
The purpose of this study is to develop a quality improvement intervention to address barriers to evidence-based acute coronary syndrome (ACS) care in northern Tanzania. Patients who presented to Kilimanjaro Christian Medical Center (KCMC) will be asked to complete a survey about barriers and facilitators of health care. In addition the survey will be administered to all providers, policymakers, and administrators participating in in-depth interviews. Data from this survey will be used to develop a quality improvement intervention that will be piloted by KCMC staff. Six months after the pilot program is implemented providers, patients, and administrators will be interviewed for their perspectives on the program.
Eligibility Criteria
Inclusion Criteria
- 18 years or older
- symptoms related to acute coronary syndrome
- myocardial infarction
- clinically sober
- able to communicate in Swahili or English
Exclusion Criteria
- medically unstable
- have a deteriorating condiction
- too critically ill to participate
Data sourced from ClinicalTrials.gov (NCT04563546). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.